EPISODE · Aug 28, 2024 · 21 MIN
Renal Cell Carcinoma
Renal cell carcinoma has an estimated lifetime prevalence of 2.3% for men and 1.3% for women in the US. Affected patients in early stages can have >94% cancer-specific survival. Author William Y. Kim, MD, of the University of North Carolina joins JAMA Associate Editor David L. Simel, MD, MHS, to discuss the epidemiology, clinical presentation, pathophysiology, and management of renal cell carcinoma. Related Content: Renal Cell Carcinoma
NOW PLAYING
Renal Cell Carcinoma
No transcript for this episode yet
Similar Episodes
Apr 21, 2026 ·73m
Apr 18, 2026 ·95m
Apr 15, 2026 ·55m
Apr 13, 2026 ·68m
Apr 11, 2026 ·59m
Apr 9, 2026 ·66m